SCHEMBL20095864

SCHEMBL20095864

CC1CN(C2CCCCC2)C1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.39
DPP4 P27487 1/20 0.35
PHGDH O43175 1/20 0.34
MGLL Q99685 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
SLC18A3 Q16572 1/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ACHE P22303 1/20 0.33
POLB P06746 2/20 0.33
GFER P55789 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27290181 1.00 SIGMAR1 (0.39) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL22271217 1.00 SIGMAR1 (0.39) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL21573246 1.00 SIGMAR1 (0.39) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL12717643 0.97 SIGMAR1 (0.36) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL12717632 0.92
SCHEMBL22422689 0.90 SIGMAR1 (0.37) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL22422691 0.90 SIGMAR1 (0.37) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL16205340 0.85
SCHEMBL10130212 0.82 DPP4 (0.43) SIGMAR1DPP4PHGDHMGLLOPRM1
SCHEMBL10130185 0.82 DPP4 (0.43) SIGMAR1DPP4PHGDHMGLLOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024036254-A2 SYNTHETIC PROCESSES AND INTERMEDIATES FOR PREPARING THERAPEUTIC AZAKETOLIDES ZIKANI THERAPEUTICS, INC. (US) 2024-02-15 WO disclosed
WO-2023247595-A1 PYRAZOLOPYRAZINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO disclosed
WO-2023235380-A1 MACROLIDES FOR TREATING GENETIC DISEASES ZIKANI THERAPEUTICS, INC. (US) 2023-12-07 WO disclosed
EP-3820574-B1 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2023-08-09 EP disclosed
WO-2018072602-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-04-26 WO disclosed
CN-102015636-A Azetidines and cyclobutanes as histamine H3 receptor antagonists EVOTEC NEUROSCIENCES GMBH 2011-04-13 CN disclosed